TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange
Background: Sickle cell hemoglobinopathies are associated with end organ damage but very rarely present with a clinical and laboratory picture of microangiopathic hemolytic anemia (MAHA) and thrombocytopenia, characteristic of thrombotic microangiopathy (TMA). Case presentation: We present a patient...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Leukemia Research Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213048919300421 |
id |
doaj-7485ae6bed354e6981f92db8cf550b19 |
---|---|
record_format |
Article |
spelling |
doaj-7485ae6bed354e6981f92db8cf550b192020-11-25T00:16:07ZengElsevierLeukemia Research Reports2213-04892019-01-0112TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchangeSreenath Kodali0Preethi Ramachandran1Ivan N. Richard2Jen-Chin Wang3Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, 11212 NY, USADivision of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, 11212 NY, USADivision of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, 11212 NY, USACorresponding author.; Division of Hematology/Oncology, Brookdale University Hospital Medical Center, Brooklyn, 11212 NY, USABackground: Sickle cell hemoglobinopathies are associated with end organ damage but very rarely present with a clinical and laboratory picture of microangiopathic hemolytic anemia (MAHA) and thrombocytopenia, characteristic of thrombotic microangiopathy (TMA). Case presentation: We present a patient with HbSC disease who developed thrombotic microangiopathy, needing both RBC exchange transfusion and therapeutic plasma exchange (TPE) for complete clinical recovery. Conclusion: Although literature showed therapeutic plasma exchange alone can abrogate a similar clinical scenario, we did an in-depth review which concluded that in most of the TMA cases secondary to sickle cell disease, treatment with both with plasma exchange and red cell exchange transfusion are necessary. Keywords: Sickle cell disease, Red cell exchange, Plasma exchange, TMAhttp://www.sciencedirect.com/science/article/pii/S2213048919300421 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sreenath Kodali Preethi Ramachandran Ivan N. Richard Jen-Chin Wang |
spellingShingle |
Sreenath Kodali Preethi Ramachandran Ivan N. Richard Jen-Chin Wang TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange Leukemia Research Reports |
author_facet |
Sreenath Kodali Preethi Ramachandran Ivan N. Richard Jen-Chin Wang |
author_sort |
Sreenath Kodali |
title |
TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange |
title_short |
TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange |
title_full |
TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange |
title_fullStr |
TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange |
title_full_unstemmed |
TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange |
title_sort |
ttp-like syndrome associated with hemoglobin sc disease treated successfully with plasma and red cell exchange |
publisher |
Elsevier |
series |
Leukemia Research Reports |
issn |
2213-0489 |
publishDate |
2019-01-01 |
description |
Background: Sickle cell hemoglobinopathies are associated with end organ damage but very rarely present with a clinical and laboratory picture of microangiopathic hemolytic anemia (MAHA) and thrombocytopenia, characteristic of thrombotic microangiopathy (TMA). Case presentation: We present a patient with HbSC disease who developed thrombotic microangiopathy, needing both RBC exchange transfusion and therapeutic plasma exchange (TPE) for complete clinical recovery. Conclusion: Although literature showed therapeutic plasma exchange alone can abrogate a similar clinical scenario, we did an in-depth review which concluded that in most of the TMA cases secondary to sickle cell disease, treatment with both with plasma exchange and red cell exchange transfusion are necessary. Keywords: Sickle cell disease, Red cell exchange, Plasma exchange, TMA |
url |
http://www.sciencedirect.com/science/article/pii/S2213048919300421 |
work_keys_str_mv |
AT sreenathkodali ttplikesyndromeassociatedwithhemoglobinscdiseasetreatedsuccessfullywithplasmaandredcellexchange AT preethiramachandran ttplikesyndromeassociatedwithhemoglobinscdiseasetreatedsuccessfullywithplasmaandredcellexchange AT ivannrichard ttplikesyndromeassociatedwithhemoglobinscdiseasetreatedsuccessfullywithplasmaandredcellexchange AT jenchinwang ttplikesyndromeassociatedwithhemoglobinscdiseasetreatedsuccessfullywithplasmaandredcellexchange |
_version_ |
1725384511791824896 |